563 research outputs found

    ๋‹ค์ค‘ ์กฐํŒŒ ์‹ ํ˜ธ ๋ถ„์„์„ ์ด์šฉํ•œ ๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ๋ฒ•

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์ž์—ฐ๊ณผํ•™๋Œ€ํ•™ ๋ฌผ๋ฆฌยท์ฒœ๋ฌธํ•™๋ถ€(๋ฌผ๋ฆฌํ•™์ „๊ณต), 2021. 2. ์ œ์›ํ˜ธ.๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ์€ ๋ฌผ์งˆ ํ‘œ๋ฉด์˜ ๊ตฌ์กฐ์™€ ํŠน์„ฑ์„ ์›์ž ๋ฐ ๋ถ„์ž ๋‹จ์œ„์—์„œ ์ธก์ •ํ•˜๋Š” ๋„๊ตฌ๋กœ์จ ์‘์ง‘๋ฌผ์งˆ ๋ฌผ๋ฆฌ๋ฟ ์•„๋‹ˆ๋ผ ํ™”ํ•™, ์ƒ๋ฌผํ•™, ์žฌ๋ฃŒ๊ณตํ•™ ๋“ฑ ๋‹ค์–‘ํ•œ ํ•™๋ฌธ์˜ ๋ฐœ์ „์— ์ด๋ฐ”์ง€ํ•˜์˜€๋‹ค. ์ด๋Ÿฌํ•œ ์—…์ ์ด ๊ฐ€๋Šฅํ–ˆ๋˜ ์ด์œ ๋Š” ๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ์ด ๋งˆ์ดํฌ๋กœ๋ฏธํ„ฐ๋ถ€ํ„ฐ ๋‚˜๋…ธ๋ฏธํ„ฐ ์ดํ•˜์˜ ๋ถ„ํ•ด๋Šฅ์œผ๋กœ ๊ตญ์†Œ์ ์ธ ์˜์—ญ์—์„œ ํƒ์นจ๊ณผ ์‹œ๋ฃŒ ์‚ฌ์ด์— ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฌผ๋ฆฌ์ ์ธ ํž˜์„ ์ธก์ •ํ•  ์ˆ˜ ์žˆ๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค. ๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ์—์„œ์˜ ํž˜ ์ธก์ •์€ ์‹œ๋ฃŒ์™€์˜ ์ƒํ˜ธ์ž‘์šฉ์œผ๋กœ ์ธํ•ด ์„ญ๋™๋œ ํƒ์นจ์˜ ์›€์ง์ž„์œผ๋กœ๋ถ€ํ„ฐ ํž˜์„ ์—ญ์‚ฐํ•˜๋Š” ํž˜ ๋ณต์›์ด๋ผ๋Š” ๊ณผ์ •์„ ๊ฑฐ์ณ์•ผ ํ•œ๋‹ค. ํ•˜์ง€๋งŒ ๊ฐ€์žฅ ์ƒ์šฉ๋˜๋Š” ํž˜ ๋ณต์› ๋ฐฉ๋ฒ•๋ก ์€ ํƒ์นจ์˜ ์ง„๋™ ์ง„ํญ์ด ์ƒํ˜ธ์ž‘์šฉ์˜ ๊ฐ์‡ ๊ธธ์ด์™€ ์ƒ์‘ํ•˜๊ฒŒ ๋˜๋ฉด ์ •ํ™•๋„๊ฐ€ ๋–จ์–ด์ง€๊ณ  ๋ณต์›์‹์ด ๋ถˆ์•ˆ์ •ํ•ด์ง„๋‹ค๋Š” ๋ฌธ์ œ์ ์ด ์ œ๊ธฐ๋˜์—ˆ๋‹ค. ํ•ด๋‹น ์ง„ํญ์—์„œ ์ด๋Ÿฌํ•œ ๋ฌธ์ œ์ ์ด ์ƒ๊ธฐ๋Š” ์ด์œ ๋Š” ๊ธฐ์กด์˜ ๋ฐฉ๋ฒ•๋ก ๋“ค์˜ ํƒ์นจ์˜ ์›€์ง์ž„์ด ๋‹จ์ˆœ ์กฐํ™” ์ง„๋™์„ ํ•˜๊ณ  ์žˆ๋‹ค๋Š” ๊ฐ€์ •์ด ํž˜์ด ๊ธ‰๊ฒฉํ•˜๊ฒŒ ๋ณ€ํ•˜๋Š” ๊ตฌ๊ฐ„์—์„œ ๊ณ ์กฐํŒŒ ์ง„๋™์ด ์ƒ๋‹นํ•ด์ง์— ๋”ฐ๋ผ ๊นจ์ง€๊ฒŒ ๋˜๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค. ๊ฒฐ๊ณผ์ ์œผ๋กœ ๋ชจ๋“  ์ง„ํญ๊ณผ ํƒ์นจ-์‹œ๋ฃŒ ๊ฑฐ๋ฆฌ์—์„œ ์œ ํšจํ•œ ์ผ๋ฐ˜์ ์ธ ํž˜ ๋ณต์› ๋ฐฉ๋ฒ•๋ก ์˜ ํ•„์š”์„ฑ์ด ๋Œ€๋‘๋˜์—ˆ๋‹ค. ์ด ๋…ผ๋ฌธ์—์„œ๋Š” ๋‹ค์ค‘ ์กฐํŒŒ ์‹ ํ˜ธ ๋ถ„์„์„ ์ด์šฉํ•œ ๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ๋ฒ•์„ ์ด๋Ÿฌํ•œ ๋ฌธ์ œ์ ์˜ ํ•ด๊ฒฐ์ฑ…์œผ๋กœ ์ œ์‹œํ•œ๋‹ค. ์ด ์ƒˆ๋กœ์šด ํ”Œ๋žซํผ์€ ๋ณดํŽธ์ ์ธ ์กฐ๊ฑด์—์„œ ๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ์˜ ํƒ์นจ์˜ ๊ณต๋ช… ์ง„๋™์ˆ˜ ์‹ ํ˜ธ๋ฟ ์•„๋‹ˆ๋ผ ๊ณ ์กฐํŒŒ ์ง„๋™์ˆ˜ ์‹ ํ˜ธ๋ฅผ ๊ณ ๋ คํ•˜์—ฌ ํž˜ ๋ณต์›์„ ํ•œ๋‹ค. ์ด ๋…ผ๋ฌธ์€ ๋‹ค์Œ ๋‹จ๊ณ„๋“ค์„ ๊ฒจ์ณ ๋‹ค์ค‘ ์กฐํŒŒ ์‹ ํ˜ธ ๊ธฐ๋ฐ˜ ํ˜„๋ฏธ๊ฒฝ๋ฒ•์„ ๊ตฌ์ถ•ํ•œ๋‹ค. ์šฐ์„ , ๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ์—์„œ ๋‚˜ํƒ€๋‚˜๋Š” ๊ณ ์กฐํŒŒ ์‹ ํ˜ธ๋ฅผ ์ด๋ก ์ ์œผ๋กœ ํƒ๊ตฌํ•œ๋‹ค. ๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ์˜ ๋‘ ๊ฐ€์ง€ ์ž‘๋™๋ฐฉ์‹์ธ ์ง„ํญ ๋ณ€์กฐ์™€ ์ฃผํŒŒ์ˆ˜ ๋ณ€์กฐ์—์„œ ์ž„์˜์˜ ๋ณด์กด๋ ฅ๊ณผ ๋น„๋ณด์กด๋ ฅ์„ ๊ฐ€์ •ํ•  ๋•Œ ์ƒ์„ฑ๋˜๋Š” ๊ณ ์กฐํŒŒ ์‹ ํ˜ธ์˜ ์ •ํ™•ํ•˜๊ณ  ํ•ด์„์ ์ธ ํ‘œํ˜„์‹์„ ๊ตฌํ•œ๋‹ค. ๊ทธ๋‹ค์Œ์œผ๋กœ ๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ์˜ ๋‘ ๊ฐ€์ง€ ์ž‘๋™๋ฐฉ์‹์„ ์œ„ํ•œ ์ผ๋ฐ˜์ ์ธ ํž˜ ๋ณต์› ๋ฐฉ๋ฒ•๋ก ์„ ์ œ์‹œํ•œ๋‹ค. ์ด ๋ฐฉ๋ฒ•๋ก ์€ ๋ชจ๋“  ์ง„๋™ ์ง„ํญ๊ณผ ํƒ์นจ-์‹œ๋ฃŒ ๊ฑฐ๋ฆฌ์— ๋Œ€ํ•ด ์ •ํ™•ํ•˜๊ฒŒ ํž˜์„ ๋ณต์›ํ•œ๋‹ค. ์ด๋Ÿฌํ•œ ์ ‘๊ทผ ๋ฐฉ์‹์€ ๊ธฐ์กด์˜ ๋ฐฉ๋ฒ•๋ก ์— ๋น„ํ•ด ๋‘ ๊ฐ€์ง€ ์ธก๋ฉด์—์„œ ์›”๋“ฑํžˆ ๋›ฐ์–ด๋‚˜๋‹ค: (i) ๋ณต์›์‹๋“ค์˜ ๊ทผ์‚ฌ์‹์„ ์‚ฌ์šฉํ•˜๋”๋ผ๋„ ๋” ๋†’์€ ์ •ํ™•๋„์™€ ๊ณ„์‚ฐ์†๋„๋กœ ํž˜์„ ๋ณต์›ํ•˜๋ฉฐ (ii) ์ง„ํญ ์˜ค๋ฅ˜์— ๋Œ€ํ•ด ๋” ๊ฐ•์ธํ•˜์—ฌ ๊ธฐ์กด ๋ฐฉ๋ฒ•๋ก ์˜ ํž˜ ๋ณต์› ๋ถˆ์•ˆ์ •์„ฑ์„ ๊ทน๋ณตํ•œ๋‹ค. ์ด ์—ฐ๊ตฌ๊ฐ€ ํ–ฅํ›„ ๋‹ค๋ฐฉ๋ฉด์˜ ๋™์—ญํ•™ ํž˜ ํ˜„๋ฏธ๊ฒฝ ์‹คํ—˜์— ์ ‘๋ชฉ๋˜์–ด ๋‹จ๋ถ„์ž ๊ฒ€์ถœ, ์›์ž ๋‹จ์œ„์˜ ๋ฌผ๋ฆฌ-ํ™”ํ•™์  ํž˜ ๊ทœ๋ช…, ์ƒˆ๋กœ์šด ์ „์ž ์ „๋‹ฌ ์„ฑ์งˆ ๋ฐœ๊ฒฌ ๋“ฑ์— ์‘์šฉ๋  ๊ฒƒ์„ ๊ธฐ๋Œ€ํ•œ๋‹ค.The success of the dynamic force microscopy (DFM) in quantifying structures and features of material surfaces at the atomic and molecular level has led to numerous progress in condensed matter physics, chemistry, biology, and material science. Its success is based on the ability to measure the local physical forces between the DFM probe and sample with spatial resolution ranging from few micrometers to sub-nanometers. Measuring forces using DFM requires conversion of the perturbed motion of the probe due to tip-sample interactions to force-distance curves, which is called force reconstruction. However, the most widely used force reconstruction method has recently been reported to yield non-negligible error and exhibit reconstruction instabilities when the oscillation amplitude is comparable to the decay length of the interaction. The main reason for these failures at such amplitudes is that the probe oscillation is no longer simply harmonic, which conventional methods assume, as higher harmonic motions become considerable at the regime where force changes rapidly. Consequently, a novel, universal force reconstruction scheme that works in all amplitudes and the entire tip-sample distances has become crucial. This thesis resolves this issue by developing DFM based on multi-harmonic signal analysis. This platform enables versatile force reconstruction using signals not only at the resonance frequency of the DFM probe, but also at its higher harmonics. Here, the following studies are performed for formulation of this new approach. First, the higher harmonic signals in DFM are theoretically analyzed. Exact, analytic expressions for higher harmonics generated from arbitrary conservative and dissipative forces are derived for two operation modes of DFM, amplitude-modulation and frequency-modulation. Moreover, universal force reconstruction formulas, which completely recover both the conservative and dissipative forces for entire oscillation amplitudes and tip-sample distances, are derived for two operation modes of DFM. This approach provides force reconstruction scheme that outperforms the conventional methods in two ways: (i) the higher accuracy at faster computation speed even by employing an approximated form of the reconstruction formulas, and (ii) the greater robustness with respect to the oscillation-amplitude error, overcoming the reconstruction instability. This thesis is expected to be of great potential importance in the field of surface science, as it may lead to a significant improvement in DFM-based experiments, including single molecule detection, identification of physicochemical interactions, and discovery of novel electron transport properties.Abstract i List of Figures vi Chapter 1 Introduction 1 1.1 Dynamic Force Microscopy 1 1.2 Force Reconstruction in Dynamic Force Microscopy 3 1.3 Multi-harmonic Atomic Force Microscopy 4 1.4 Outline of the Thesis 5 Chapter 2 Generation of Higher Harmonics in Dynamic Force Microscopy 14 2.1 Introduction 14 2.2 Theoretical Formulation 15 2.2.1 Amplitude-Modulation MHAFM 17 2.2.2 Frequency-Modulation MHAFM 19 2.3 Simulation Results 21 2.4 Conclusion 26 Chapter 3 Force Reconstruction in Dynamic Force Microscopy using Multi-harmonic Signal Analysis 30 3.1 Introduction 30 3.2 Theoretical Formulation 31 3.2.1 Amplitude-Modulation MHAFM 31 3.2.2 Frequency-Modulation MHAFM 33 3.3 Reconstruction Results 35 3.4 Conclusion 45 Chapter 4 Conclusion 47 ์ดˆ๋ก 49Maste

    ๋ฌด์งˆ์„œํ•œ ๋น„๋“ฑ๋ฐฉ์„ฑ๊ณ„์—์„œ์˜ ์ง๋ฅ˜ ์ „๋„๋„์— ๋Œ€ํ•œ ๋‹ค์ด์–ด๊ทธ๋žจ ์ ‘๊ทผ๋ฒ•

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์ž์—ฐ๊ณผํ•™๋Œ€ํ•™ ๋ฌผ๋ฆฌยท์ฒœ๋ฌธํ•™๋ถ€(๋ฌผ๋ฆฌํ•™์ „๊ณต), 2020. 8. ๋ฏผํ™๊ธฐ.Transport in disordered systems is one of central themes in condensed matter physics. For systems with an isotropic energy dispersion, various theoretical approaches, including the Boltzmann transport theory and the Kubo formula, have provided us with useful frameworks for studying transport in disordered systems. Notably, it turns out that the two approaches give the consistent correction to dc conductivity in isotropic systems. However, it has been elusive to correctly compute transport properties of systems with an arbitrarily anisotropic Fermi surface, especially by using a diagrammatic approach. Motivated by this point, this thesis is devoted to the development of a diagrammatic formalism for computing the dc conductivity of anisotropic systems. We start by developing a generalized theory of transport in the semiclassical regime (i.e. kFโ„“eโ‰ซ1k_{\rm F}\ell_{e}\gg 1), in the presence of electron-impurity and electron-phonon scatterings, respectively. First, we brief on the semiclassical Boltzmann approach in anisotropic multiband systems. Next, using the Kubo formula, we study the ladder approximation in anisotropic multiband systems and derive a relation satisfied by the transport relaxation time. As a result, we verify that the two theories are generally equivalent. Then we turn to a unique transport feature in the quantum regime (i.e. kFโ„“eโˆผ1k_{\rm F}\ell_{e}\sim1), so-called weak localization. We rewrite the Bethe-Salepter equation and derive a Cooperon ansatz, which captures the anisotropy and Berry phase of the system. Using this ansatz, we develop a systematic quantum interference theory and apply it to various phases of few-layer black phosphorus. As a result, we predict that the magnetoconductivity at the semi-Dirac transition point will exhibit a nontrivial power-law dependence on the magnetic field, while following the conventional logarithmic field dependence of two-dimensional systems in the insulator and Dirac semimetal phases. Notably, the ratio between the magnetoconductivity and Boltzmann conductivity turns out to be independent of the direction, even in strongly anisotropic systems.๋ถˆ์ˆœ๋ฌผ์ด ์žˆ๋Š” ๊ณ„์—์„œ์˜ ์ „ํ•˜ ์ˆ˜์†ก์€ ์‘์ง‘ ๋ฌผ์งˆ ๋ฌผ๋ฆฌ์˜ ์ค‘์š”ํ•œ ์—ฐ๊ตฌ ์ฃผ์ œ ์ค‘ ํ•˜๋‚˜์ด๋‹ค. ๋“ฑ๋ฐฉ์„ฑ ์—๋„ˆ์ง€ ๋ถ„์‚ฐ์„ ๊ฐ€์ง€๋Š” ๊ณ„์—์„œ๋Š” ๋ณผ์ธ ๋งŒ ์ˆ˜์†ก ์ด๋ก ๊ณผ ๋‹ค์ด์–ด๊ทธ๋žจ ์ ‘๊ทผ๋ฒ• (diagrammatic approach) ๋“ฑ์„ ํ†ตํ•ด ์ „๊ธฐ ์ „๋„๋„๋ฅผ ๊ณ„์‚ฐํ•˜๋Š” ๋ฐฉ๋ฒ•์ด ์ž˜ ๊ตฌ์ถ•๋˜์–ด ์žˆ๋‹ค. ์ด์™€ ๋‹ฌ๋ฆฌ ๋น„๋“ฑ๋ฐฉ์„ฑ ์—๋„ˆ์ง€ ๋ถ„์‚ฐ์„ ๊ฐ€์ง€๋Š” ๊ณ„์˜ ์ „๊ธฐ ์ „๋„๋„๋ฅผ ์ •ํ™•ํžˆ ๊ณ„์‚ฐํ•˜๋Š” ๊ฒƒ์€ ๊นŒ๋‹ค๋กœ์šด ๋ฌธ์ œ์ด๋‹ค. ์ด์— ๋ณธ ๋…ผ๋ฌธ์—์„œ๋Š” ๋‹ค์ด์–ด๊ทธ๋žจ ์ ‘๊ทผ๋ฒ•์„ ์ด์šฉํ•ด ๋น„๋“ฑ๋ฐฉ์„ฑ๊ณ„์˜ ์ˆ˜์†ก ์„ฑ์งˆ์„ ์—ฐ๊ตฌํ•˜๊ธฐ ์œ„ํ•œ ์—„๋ฐ€ํ•œ ๊ณ„์‚ฐ ์ฒด๊ณ„๋ฅผ ๊ณ ์•ˆํ•˜์˜€๋‹ค. ์ฒซ์งธ๋กœ ๋น„๋“ฑ๋ฐฉ์„ฑ ๋‹ค์ธต๋ ๋ฅผ ๊ฐ€์ง€๋Š” ๊ณ„์—์„œ์˜ ๊ณ ์ „์ ์ธ ์ˆ˜์†ก ์ด๋ก ์„ ๊ตฌ์ถ•ํ•˜์˜€๋‹ค. ๋จผ์ € ๋ณผ์ธ ๋งŒ ์ˆ˜์†ก ์ด๋ก ์„ ์ผ๋ฐ˜ํ™”ํ•˜์˜€๊ณ , ๊ทธ ๋‹ค์Œ ์‚ฌ๋‹ค๋ฆฌ ๋‹ค์ด์–ด๊ทธ๋žจ์ด ์ „๊ธฐ ์ „๋„๋„์— ์ฃผ๋Š” ๋ณด์ •์„ ๊ณ„์‚ฐํ•˜์—ฌ ์ˆ˜์†ก ํ’€๋ฆผ ์‹œ๊ฐ„ (transport relaxation time) ์ด ๋งŒ์กฑํ•˜๋Š” ๊ด€๊ณ„์‹์„ ์–ป์—ˆ๋‹ค. ์ด๋ฅผ ํ†ตํ•ด ๋‘ ์ด๋ก ์ด ์ผ๋ฐ˜์ ์œผ๋กœ ๊ฐ™์€ ๊ฒฐ๊ณผ๋ฅผ ์ค€๋‹ค๋Š” ๊ฒƒ์„ ๋ณด์˜€๋‹ค. ๋˜ํ•œ ์–‘์ž ์˜์—ญ์—์„œ์˜ ๋…ํŠนํ•œ ์ˆ˜์†ก ํ˜„์ƒ์ธ ์•ฝํ•œ ๊ตญ์†Œํ™”์— ๋Œ€ํ•ด ์—ฐ๊ตฌํ•˜์˜€๋‹ค. ๋จผ์ € ๋น„๋“ฑ๋ฐฉ์„ฑ๊ณ„์—์„œ ๋ฒ ํ…Œ-์ƒํ”ผํ„ฐ (Bethe-Salpeter) ๋ฐฉ์ •์‹์˜ ์ฟ ํŽ˜๋ก  (Cooperon) ํ•ด๋ฅผ ์œ ๋„ํ•˜์˜€๊ณ , ์ด๋ฅผ ์ด์šฉํ•ด ๋‹ค์ธต ํ‘๋ฆฐ์˜ ์—ฌ๋Ÿฌ ์ƒ (phase) ์—์„œ ์•ฝํ•œ ๊ตญ์†Œํ™”๋ฅผ ์—ฐ๊ตฌํ•˜์˜€๋‹ค. ๊ทธ ๊ฒฐ๊ณผ, ๋‹ค๋ฅธ ์ƒ๋“ค๊ณผ ๋‹ฌ๋ฆฌ ๋ฐ˜-๋””๋ฝ ์ค€๊ธˆ์† ์ „์ด์  (semi-Dirac transition point) ์—์„œ ์ž๊ธฐ ์ „๋„๋„์˜ ์ž๊ธฐ์žฅ ์˜์กด์„ฑ์ด ๋…ํŠนํ•œ ๋ฉฑ๋ฒ•์น™์„ ๋”ฐ๋ฆ„์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋˜ํ•œ ์ž๊ธฐ ์ „๋„๋„์™€ ๋ณผ์ธ ๋งŒ ์ „๋„๋„์˜ ๋น„์œจ์ด ๋ฐฉํ–ฅ ์˜์กด์„ฑ์„ ๊ฐ€์ง€์ง€ ์•Š์Œ์„ ์ฆ๋ช…ํ•˜์˜€๋‹ค.1 Introduction 1 2 Semiclassical Boltzmann transport theory 5 2.1 Elastic scattering 5 2.2 Inelastic scattering 7 3 Ladder vertex corrections 9 3.1 Impurity scattering 10 3.2 Phonon scattering 14 3.3 Ward identities 19 3.4 Alternative derivations for the vertex corrections 20 3.5 Discussion 23 4 Quantum interference corrections 24 4.1 Bethe-Salpeter equation 24 4.2 Cooperon ansatz 26 5 Quantum interference effects in few-layer black phosphorus 28 5.1 Model 29 5.2 Weak localization and antilocalization 30 5.2.1 Insulator phase and SDTP 31 5.2.2 DSM phase with intranode scattering 32 5.2.3 DSM phase with internode scattering 34 5.3 Magnetoconductivity 35 5.3.1 Insulator phase 35 5.3.2 DSM phase 37 5.3.3 SDTP 38 5.4 Discussion 41 6 Conclusion 44Maste

    ๊ณ ์–‘์ด ๋™๋งฅํ˜ˆ์ „์ƒ‰์ „์ฆ์— ์ ์šฉํ•œ Tissue Plasminogen Activator์™€ Rivaroxaban์˜ ํšจ๊ณผ์™€ ์น˜๋ฃŒ๊ฒฐ๊ณผ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต๋Œ€ํ•™์› : ์ˆ˜์˜๊ณผ๋Œ€ํ•™ ์ˆ˜์˜ํ•™๊ณผ, 2023. 2. Inhyung Lee.Thrombolytic therapy is beneficial for reestablishing arterial blood flow, but its use is restricted because of its side effects, including hemorrhagic complications and reperfusion injuries. This study aimed to report the outcomes of acute feline arterial thromboembolism (ATE) treated with tissue plasminogen activator (tPA) and the factor Xa inhibitor, rivaroxaban (RVX). This retrospective observational study recruited 16 cats with feline ATE treated between July 2017 and July 2021 from a referral animal hospital in South Korea. Seven and nine cats were treated with dual (tPA + RVX) therapy and only RVX therapy, respectively. Medical records were reviewed for evidence of adverse eventsโ€”hemorrhagic complications, hyperkalemia, and reperfusion injuryโ€”and clinical conditions at admission. The primary outcome was survival to discharge, and the principal safety outcome was major bleeding. The day to complete ATE resolution, which was confirmed via vascular ultrasound, was 7.3 ยฑ 4.5 days in the dual therapy group. In all 16 cats, three cats and four cats in the dual therapy group and RVX group, respectively, experienced bleeding complications. The median survival time for all cats was 29 days (range 1โ€“1574 days), 386 days (range 42โ€“1574 days) in dual therapy group, and 5 days (range 1โ€“344 days) in RVX group. The recurrence rate of ATE while on therapy was 6.2%, in which this cat did not receive consistent medication, and the time to recurrence was 379 days. In conclusion, dual therapy with tPA and rivaroxaban resulted in increased survival rates than conservative therapy for acute feline ATE.๊ณ ์–‘์ด ๋™๋งฅํ˜ˆ์ „์ƒ‰์ „์ฆ์—์„œ ํ˜ˆ์ „์šฉํ•ด์น˜๋ฃŒ๋ฒ•์€ ๋™๋งฅ ํ˜ˆ๋ฅ˜์˜ ์žฌ๊ด€๋ฅ˜์— ๋„์›€์„ ์ฃผ์–ด ์ž„์ƒ์ฆ์ƒ์„ ๊ฐœ์„ ์‹œํ‚จ๋‹ค. ํ•˜์ง€๋งŒ ํ˜ˆ์ „์šฉํ•ด์น˜๋ฃŒ๋ฒ•์— ๋”ฐ๋ฅด๋Š” ์ถœํ˜ˆ ๋ฐ ์žฌ๊ด€๋ฅ˜ ์†์ƒ์˜ ์ƒ๋ช…์„ ์œ„ํ˜‘ํ•˜๋Š” ๋ถ€์ž‘์šฉ์œผ๋กœ ์ธํ•ด ์‚ฌ์šฉ์ด ์ œํ•œ๋˜๊ณ  ์žˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ๊ณ ์–‘์ด ๋™๋งฅํ˜ˆ์ „์ƒ‰์ „์ฆ์—์„œ tissue plasminogen activator (tPA)์™€ rivaroxaban์„ ์ ์šฉํ•˜์—ฌ ์น˜๋ฃŒํ•œ ๊ฒฐ๊ณผ๋ฅผ ๋ณด๊ณ ํ•˜๊ณ ์ž ์‹ค์‹œํ•˜์˜€๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” 2017๋…„ 7์›”๋ถ€ํ„ฐ 2021๋…„ 7์›”๊นŒ์ง€ ์ด์ฐจ์ง„๋ฃŒ ๋™๋ฌผ๋ณ‘์›์—์„œ ๊ณ ์–‘์ด ๋™๋งฅํ˜ˆ์ „์ƒ‰์ „์ฆ ์น˜๋ฃŒ๋ฅผ ๋ฐ›์€ 16๋งˆ๋ฆฌ์˜ ๊ณ ์–‘์ด๋ฅผ ๋Œ€์ƒ์œผ๋กœ ์‹ค์‹œํ•˜์˜€๋‹ค. 16๋งˆ๋ฆฌ์˜ ๊ณ ์–‘์ด ์ค‘์—์„œ 7๋งˆ๋ฆฌ๋Š” dual ์š”๋ฒ•(tPA + rivaroxaban)์œผ๋กœ ์น˜๋ฃŒํ•˜์˜€์œผ๋ฉฐ, 9๋งˆ๋ฆฌ๋Š” rivaroxaban ๋‹จ๋…์š”๋ฒ•์œผ๋กœ ์น˜๋ฃŒํ•˜์˜€๋‹ค. ์ง„๋ฃŒ ๊ธฐ๋ก์€ ์‘๊ธ‰ ๋‚ด์› ๋‹น์‹œ์˜ ์ž„์ƒ ์ฆ์ƒ๊ณผ ์น˜๋ฃŒ ์ค‘์— ๋ฐœ์ƒํ•˜๋Š” ์ถœํ˜ˆ์„ฑ ํ•ฉ๋ณ‘์ฆ, ๊ณ ์นผ๋ฅจํ˜ˆ์ฆ, ์žฌ๊ด€๋ฅ˜ ์†์ƒ๊ณผ ๊ฐ™์€ ๋ถ€์ž‘์šฉ์„ ํ™•์ธํ•˜๊ธฐ ์œ„ํ•ด ๊ฒ€ํ† ๋˜์—ˆ๋‹ค. ์น˜๋ฃŒ์˜ ์ฃผ์š”ํ•œ ๋ชฉํ‘œ๋Š” ์ƒ์กดํ•˜์—ฌ ํ‡ด์›ํ•˜๋Š” ๊ฒƒ์ด์—ˆ๋‹ค. Dual ์š”๋ฒ•๊ตฐ์—์„œ ํ˜ˆ์ „์šฉํ•ด์ œ (tPA) ํˆฌ์—ฌ ํ›„ ํ˜ˆ๊ด€ ์ดˆ์ŒํŒŒ๋ฅผ ํ†ตํ•ด ํ™•์ธ๋œ ๋™๋งฅํ˜ˆ์ „์ƒ‰์ „์˜ ์™„์ „ ์†Œ์‹ค ํ™•์ธ๊ธฐ๊ฐ„(์ผ)์€ 7.3 ยฑ 4.5 ๋กœ ํ™•์ธ๋๋‹ค. Dual ์š”๋ฒ•๊ตฐ๊ณผ rivaroxaban ๋‹จ๋…์š”๋ฒ•๊ตฐ์— ์†ํ•œ ๊ณ ์–‘์ด 3๋งˆ๋ฆฌ (42%)์™€ 4๋งˆ๋ฆฌ (44%)์—์„œ ์ถœํ˜ˆ์„ฑ ํ•ฉ๋ณ‘์ฆ์ด ๋‚˜ํƒ€๋‚ฌ๋‹ค. ๋ชจ๋“  ๊ณ ์–‘์ด์˜ ํ‰๊ท  ์ƒ์กด ๊ธฐ๊ฐ„์˜ ์ค‘์•™๊ฐ’์€ 29์ผ์ด์—ˆ์œผ๋ฉฐ, Dual ์š”๋ฒ•๊ตฐ๊ณผ rivaroxaban ๋‹จ๋…์š”๋ฒ•๊ตฐ์—์„œ ํ‰๊ท  ์ƒ์กด ๊ธฐ๊ฐ„์˜ ์ค‘์•™๊ฐ’์€ ๊ฐ๊ฐ 386์ผ๊ณผ 5์ผ์ด์—ˆ๋‹ค. ์น˜๋ฃŒ ์ค‘ ๋™๋งฅํ˜ˆ์ „์ƒ‰์ „์ฆ์˜ ์žฌ๋ฐœ๋ฅ ์€ 6.2% ์ด์—ˆ๋‹ค. ํ•ด๋‹น ๊ณ ์–‘์ด๋Š” ๊ฒฝ๊ตฌ์•ฝ๋ฌผ์น˜๋ฃŒ๋ฅผ ์ค‘๋‹จํ•œ ์ดํ›„ ๋™๋งฅํ˜ˆ์ „์ƒ‰์ „์ฆ์ด ์žฌ๋ฐœํ•œ ๊ฒƒ์ด์—ˆ์œผ๋ฉฐ, ์ค‘๋‹จ์ผ๋กœ๋ถ€ํ„ฐ ์žฌ๋ฐœ๊นŒ์ง€์˜ ๊ธฐ๊ฐ„์€ 379์ผ์ด์—ˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๋ฅผ ํ†ตํ•ด ๊ณ ์–‘์ด ๋™๋งฅํ˜ˆ์ „์ƒ‰์ „์ฆ์— tPA์™€ rivaroxaban์„ ํ•จ๊ป˜ ์ ์šฉํ•œ dual ์š”๋ฒ•์˜ ์น˜๋ฃŒ๊ฐ€ ํ˜ˆ์ „์šฉํ•ด์ œ๋ฅผ ์‚ฌ์šฉํ•˜์ง€ ์•Š๋Š” ๊ธฐ์กด์˜ ์น˜๋ฃŒ ์š”๋ฒ•๋ณด๋‹ค ์ƒ์กด์œจ์„ ์ฆ๊ฐ€์‹œํ‚ค๋Š” ๊ฒƒ์„ ํ™•์ธํ–ˆ๋‹ค.Introduction 1 Materials and Methods 4 Statistical Methods 7 Results 9 1. Study population and characteristics 9 2. Adverse events 11 3. Clinical outcomes 11 4. Table 1 13 5. Table 2 14 6. Table 3 15 7. Figure 1 16 8. Figure 2 17 Discussion 18 Conclusions 24 References 25 Abstract in Korean 31์„

    ์‹คํ—˜์ ์œผ๋กœ ์œ ๋„๋œ ์—ผ์ฆ ๋ฐ ์•”ํ™” ๋ชจ๋ธ์—์„œ 17-oxo-docosahexaenoic acid ๋ฐ taurine chloramine์˜ ๋ณดํ˜ธ ํšจ๊ณผ ๋ฐ ๊ธฐ์ „ ์—ฐ๊ตฌ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ(๋ฐ•์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต๋Œ€ํ•™์› : ์•ฝํ•™๋Œ€ํ•™ ์•ฝํ•™๊ณผ, 2023. 2. ์„œ์˜์ค€.Taurine chloramine (TauCl)์€ ์œก๋ฅ˜, ์ƒ์„ , ๊ณ„๋ž€ ๋ฐ ์šฐ์œ ๋ฅผ ํฌํ•จํ•œ ์ผ๋ถ€ ์‹ํ’ˆ์—์„œ ๋ฐœ๊ฒฌ๋˜๋Š”, ์ค€ํ•„์ˆ˜ ํ™ฉ ํ•จ์œ  ฮฒ-์•„๋ฏธ๋…ธ์‚ฐ์ธ Taurine์—์„œ ๋Œ€์‚ฌ๋œ ๋‚ด์ธ์„ฑ ํ•ญ์—ผ์ฆ ๋ฌผ์งˆ์ด๋‹ค. ์ผ๋ฐ˜์ ์œผ๋กœ TauCl๊ณผ Taurine์€ ๋‹ค์–‘ํ•œ ์œ ํ˜•์˜ ์„ธํฌ์—์„œ ์กฐ์ง ์†์ƒ์— ์˜ํ•ด ์œ ๋ฐœ๋˜๋Š” ์—ผ์ฆ ๋งค๊ฐœ์ฒด์˜ ์ƒ์„ฑ์„ ๊ฐ์†Œ์‹œํ‚จ๋‹ค. ๋ณธ ๋…ผ๋ฌธ์—ฐ๊ตฌ์—์„œ ์‹คํ—˜์ ์œผ๋กœ ์œ ๋„๋œ ๋Œ€์žฅ์—ผ์— ๋Œ€ํ•œ TauCl์˜ ๋ณดํ˜ธ ํšจ๊ณผ๋ฅผ ํ™•์ธํ•˜์˜€๋‹ค. 2,4,6-Trinitrobenzene sulfonic acid (TNBS)์— ์˜ํ•ด ์œ ๋„๋œ ๋Œ€์žฅ์—ผ์ฆ์€ TauCl์˜ ๊ฒฝ๊ตฌ ํˆฌ์—ฌ์— ์˜ํ•ด ๊ฒฝ๊ฐ๋˜์—ˆ๋‹ค. ๋˜ํ•œ TauCl์˜ ํˆฌ์—ฌ๋Š” TNBS๋กœ ์œ ๋„๋œ ๋งˆ์šฐ์Šค์˜ ๋Œ€์žฅ ์ ๋ง‰์—์„œ ์„ธํฌ์ž๋ฉธ์‚ฌ๋ฅผ ๊ฐ์†Œ์‹œ์ผฐ๋‹ค. ์ด๋Š” necrosis factor-ฮฑ, interleukin-6 ์™€ cyclooxygenase-2 (COX-2)๋ฅผ ํฌํ•จํ•˜๋Š” ์—ผ์ฆ์„ฑ ์ธ์ž์™€ 4-hydroxy-2-nonenal (4-HNE)์„ ํฌํ•จํ•˜๋Š” ์‚ฐํ™”์  ์ŠคํŠธ๋ ˆ์Šค ์ธ์ž์˜ ์–ต์ œ๋ฅผ ํ†ตํ•ด ํ™•์ธ๋˜์—ˆ๋‹ค. TauCl์€ ๋˜ํ•œ ์—ผ์ฆ ์‹ ํ˜ธ์ „๋‹ฌ์„ ๋งค๊ฐœํ•˜๋Š” ๋‘ ๊ฐ€์ง€ ์ฃผ์š” ์ „์‚ฌ ์ธ์ž์ธ nuclear factor kappa light chain enhancer of activated B cells (NFฮบB) ๋ฐ signal transducer and activator of transcription 3 (STAT3)์˜ ํ™œ์„ฑํ™”๋ฅผ ์–ต์ œํ•˜์˜€๋‹ค. ํŠนํžˆ, TNBS๋กœ ์œ ๋„๋œ ๋งˆ์šฐ์Šค์˜ ๋Œ€์žฅ์—์„œ ์‚ฐํ™”์  ์ŠคํŠธ๋ ˆ์Šค ๋ฐ ์—ผ์ฆ์— ๋Œ€ํ•œ TauCl์˜ ๋ณดํ˜ธ ํšจ๊ณผ๋Š” nuclear factor erythroid 2-related factor 2 (Nrf2)์˜ ๋†’์€ ํ™œ์„ฑํ™” ๋ฐ heme oxygenase-1 (HO-1), NAD(P)H:quinone oxidoreductase (NQO1)๊ณผ ๊ฐ™์€ ํ‘œ์  ์œ ์ „์ž์˜ ๋ฐœํ˜„ ๋Ÿ‰ ์ฆ๊ฐ€์™€ ๊ด€๋ จ์ด ์žˆ์Œ์„ ๊ด€์ฐฐํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ์ด๋Ÿฌํ•œ ๊ฒฐ๊ณผ๋Š” TauCl์ด Nrf2์— ์˜ํ•ด ์œ ๋„๋˜๋Š” ํ•ญ์‚ฐํ™” ์œ ์ „์ž ๋ฐœํ˜„์˜ ์ƒํ–ฅ์กฐ์ ˆ์„ ํ†ตํ•ด ๋Œ€์žฅ์—ผ์— ๋Œ€ํ•œ ๋ณดํ˜ธํšจ๊ณผ๋ฅผ ๋ณด์ž„๊ณผ ๋™์‹œ์—, NFฮบB์™€ STAT3์— ์˜ํ•ด ๋งค๊ฐœ๋˜๋Š” ์—ผ์ฆ์„ฑ ์‹ ํ˜ธ๋ฅผ ์–ต์ œํ•จ์„ ๋‚˜ํƒ€๋‚ธ๋‹ค. ํƒœ์–‘๊ด‘, ํŠนํžˆ ์ž์™ธ์„ ์— ๋Œ€ํ•œ ๊ณผ๋„ํ•œ ๋…ธ์ถœ์€ ๊ด‘๋…ธํ™”๋ฅผ ์ผ์œผํ‚ค๋ฉฐ ํ”ผ๋ถ€์—ผ ๋ฐ ํ”ผ๋ถ€์•” ๋ฐœ์ƒ์˜ ์ฃผ์š” ์›์ธ์ด๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ๊ด‘์†์ƒ์œผ๋กœ๋ถ€ํ„ฐ ํ”ผ๋ถ€๋ฅผ ํšจ๊ณผ์ ์œผ๋กœ ๋ณดํ˜ธํ•  ์ˆ˜ ์žˆ๋Š” ํ›„๋ณด ๋ฌผ์งˆ์„ ์ฐพ๊ธฐ ์œ„ํ•ด ์—ผ์ฆ ์กฐ์ง์œผ๋กœ ์ง‘์ค‘๋œ ๋Œ€์‹์„ธํฌ์˜ Taurine์œผ๋กœ๋ถ€ํ„ฐ ์ƒ์„ฑ๋˜๋Š” TauCl์„ ์‚ฌ์šฉํ•˜์—ฌ ์ˆ˜ํ–‰๋˜์—ˆ๋‹ค. 180 mJ/cm2 ๊ฐ•๋„์˜ Ultraviolet B (UVB) ์กฐ์‚ฌ๋Š” ๋งˆ์šฐ์Šค ํ‘œํ”ผ์—์„œ ์‚ฐํ™”์  ์†์ƒ๊ณผ ์„ธํฌ ์‚ฌ๋ฉธ์„ ์œ ๋ฐœํ•˜์˜€๋‹ค. TUNEL-์–‘์„ฑ ํ‘œํ”ผ ์„ธํฌ์˜ ๊ฐ์†Œ ๋ฐ ์„ธํฌ์‚ฌ๋ฉธ ์–ต์ œ ๋‹จ๋ฐฑ์งˆ์ธ Bcl-xL์˜ ๋ฐœํ˜„๋Ÿ‰ ์ฆ๊ฐ€, cleaved caspase-3์˜ ๊ฐ์†Œ ๋ฐ 4-HNE์˜ ์–ต์ œ์— ์˜ํ•ด ์ž…์ฆ๋œ ๋ฐ”์™€ ๊ฐ™์ด ์ด๋Ÿฌํ•œ ํ”ผ๋ถ€์—ผ์ฆ์€ ๊ตญ์†Œ ๋„ํฌ ์ฒ˜๋ฆฌ๋œ TauCl์— ์˜ํ•ด ๊ฒฝ๊ฐ๋จ์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋˜ํ•œ ๋‘ ๊ฐ€์ง€ ์ฃผ์š” ์—ผ์ฆ ํšจ์†Œ์ธ COX-2์™€ inducible nitric oxide synthase (iNOS)์˜ ๋ฐœํ˜„์€ TauCl ์ฒ˜๋ฆฌ๋œ ๋งˆ์šฐ์Šค์—์„œ ์œ ์˜ํ•˜๊ฒŒ ๋‚ฎ์Œ์„ ํ™•์ธํ•˜์˜€๊ณ , ์—ผ์ฆ์„ฑ ์‚ฌ์ดํ† ์นด์ธ (Tnf, Il6, Il1b, Il10)์˜ ์ „์‚ฌ ๋˜ํ•œ ์œ ์‚ฌํ•œ ๊ฒฝํ–ฅ์„ฑ์„ ๋‚˜ํƒ€๋‚ด๋Š” ๊ฒƒ์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋˜ํ•œ TauCl์˜ ํ•ญ์—ผ์ฆ ํšจ๊ณผ๋Š” STAT3์˜ ํ™œ์„ฑํ™” ์–ต์ œ ๋ฐ Nrf2์˜ ํ™œ์„ฑํ™”๋ฅผ ํ†ตํ•œ HO-1, NQO1๊ณผ ๊ฐ™์€ ํ•ญ์‚ฐํ™” ํšจ์†Œ์˜ ์œ ๋„ ์™€๋„ ๊ด€๋ จ ์žˆ์Œ์„ ํ™•์ธํ•˜์˜€๋‹ค. ์ด๋Ÿฌํ•œ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๋“ค์„ ํ†ตํ•ด ๋Œ€์žฅ์—ผ ๋ฐ ํ”ผ๋ถ€์—ผ์— ๋Œ€ํ•œ TauCl์˜ ํ™”ํ•™์  ์•”์˜ˆ๋ฐฉํšจ๊ณผ๋Š” ์—ผ์ฆ์„ ๋งค๊ฐœํ•˜๋Š” ํ‘œ์  ๋‹จ๋ฐฑ์งˆ๋“ค์˜ ํ™œ์„ฑํ™”๋ฅผ ๊ฒฝ๊ฐ์‹œํ‚ด๊ณผ ๋™์‹œ์— ํ™œ์„ฑ์‚ฐ์†Œ์ข…์˜ ์ œ๊ฑฐ์™€ ๊ด€๋ จ๋œ ํ•ญ์‚ฐํ™” ๋‹จ๋ฐฑ์งˆ๋“ค์˜ ์ฆ๊ฐ€๋œ ๋ฐœํ˜„์„ ํ†ตํ•ด ๋งค๊ฐœ๋œ๋‹ค๊ณ  ํ•  ์ˆ˜ ์žˆ๋‹ค. ๊ธ‰์„ฑ ์—ผ์ฆ์€ ์กฐ์ง ๋ณต๊ตฌ์™€ ํ•ญ์ƒ์„ฑ ํšŒ๋ณต์„ ์œ„ํ•œ ์ž๊ธฐ ํ•œ์ •์  ๊ณผ์ •์ด๋‹ค. ๊ธ‰์„ฑ ์—ผ์ฆ์ด ์ ์ ˆํ•˜๊ฒŒ ํ•ด์†Œ๋˜์ง€ ์•Š์œผ๋ฉด ์—ผ์ฆ ๋ฐ˜์‘์ด ์ง€์†๋˜์–ด ์ฒœ์‹, ๊ด€์ ˆ์—ผ, ๋™๋งฅ๊ฒฝํ™”์ฆ, ์‹ฌ์ง€์–ด ์•” ๊ณผ๋„ ๊ฐ™์€ ์—ฌ๋Ÿฌ ๋งŒ์„ฑ ์งˆํ™˜์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค. ์„ธํฌ์ž์—ฐ์‚ฌ๋Š” ์กฐ์ง์˜ ์—ผ์ฆ ํ•ด์†Œ ๋‹จ๊ณ„์—์„œ ๊ด€์ฐฐ๋˜๋Š” ์„ธํฌ์˜ˆ์ •์‚ฌ์˜ ๊ฐ€์žฅ ์ค‘์š”ํ•œ ๊ณผ์ •์ด๋‹ค. ์ฃฝ๊ฑฐ๋‚˜ ์ฃฝ์–ด๊ฐ€๋Š” ์„ธํฌ์˜ ์ถ•์ ์€ ์ง€์†์ ์ธ ์—ผ์ฆ ๋ฐ˜์‘์„ ์ผ์œผํ‚ค๊ฑฐ๋‚˜ ์•…ํ™”์‹œํ‚ค๊ธฐ ๋•Œ๋ฌธ์— ์„ธํฌ ์‚ฌ๋ฉธ ์„ธํฌ์˜ ์ œ๊ฑฐ๋Š” ์—ผ์ฆ ์กฐ์ ˆ์— ํ•„์ˆ˜์ ์ธ ์—ญํ• ์„ ํ•œ๋‹ค. ํฌ์‹์ž‘์šฉ์€ ๋Œ€์‹์„ธํฌ์˜ ์‹์„ธํฌ ์ž‘์šฉ์— ์˜ํ•ด ์ฃฝ๊ฑฐ๋‚˜ ์ฃฝ์–ด๊ฐ€๋Š” ์„ธํฌ๊ฐ€ ์ œ๊ฑฐ๋˜๋Š” ๊ณผ์ •์ด๋‹ค. CD36์„ ํฌํ•จํ•œ ๋‹ค์–‘ํ•œ ์‹์„ธํฌ ์ˆ˜์šฉ์ฒด๋Š” ์‹๊ท  ์ž‘์šฉ์„ ํ•˜๋Š” ๊ฒƒ์œผ๋กœ ์—ฌ๊ฒจ์ง€๋Š” ์„ธํฌ๋ฅผ ์ธ์‹ํ•จ์œผ๋กœ์จ ์ด ๊ณผ์ •์— ๊ด€์—ฌํ•œ๋‹ค. ํฌ์‹์ž‘์šฉ์€ ์—ผ์ฆ์˜ ํ•ด์†Œ์— ๊ธฐ์—ฌํ•จ์œผ๋กœ์จ 2์ฐจ ๊ดด์‚ฌ, ์—ผ์ฆ์˜ ์‹ฌํ™”, ๊ทธ๋ฆฌ๊ณ  ๋งŒ์„ฑ ์—ผ์ฆ์„ ์˜ˆ๋ฐฉํ•˜๋Š”๋ฐ ํ•„์ˆ˜์ ์ธ ์—ญํ• ์„ ํ•œ๋‹ค. ์™ธ๋ถ€ ๋ฐ ๋‚ด๋ถ€ ์—ผ์ฆ ์ž๊ทน์— ๋ฐ˜์‘ํ•˜์—ฌ ํ•ญ์ƒ์„ฑ์„ ์œ ์ง€ํ•˜๋Š” ๊ฐ€์žฅ ์ค‘์š”ํ•œ ๊ด€๋ฌธ์ด์ž ๊ธฐ๊ด€์œผ๋กœ์„œ ํ”ผ๋ถ€์˜ ์ค‘์š”์„ฑ์€ ์•„๋ฌด๋ฆฌ ๊ฐ•์กฐํ•ด๋„ ์ง€๋‚˜์น˜์ง€ ์•Š๋Š”๋‹ค. ํ‘œํ”ผ์—์„œ ๊ธ‰์„ฑ ์—ผ์ฆ์˜ ํ•ด์†Œ๊ฐ€ ์ œ๋Œ€๋กœ ์ด๋ฃจ์–ด์ง€์ง€ ์•Š์œผ๋ฉด ์—ผ์ฆ์˜ ์ค‘์ฆ๋„๋ฅผ ์•…ํ™”์‹œํ‚ฌ ์ˆ˜ ์žˆ๋‹ค. Docosahexaenoic acid (DHA)๋Š” ์˜ค๋ฉ”๊ฐ€3 ๋ถˆํฌํ™”์ง€๋ฐฉ์‚ฐ ์ค‘ ํ•˜๋‚˜๋กœ, ๋Œ€์‚ฌ๊ณผ์ •์„ ๊ฑฐ์ณ ์ƒ๋ฌผํ•™์ ์œผ๋กœ ํ™œ์„ฑํ™”๋œ ์นœ์ „์ž์„ฑ ๋Œ€์‚ฌ์ฒด๋ฅผ ์ƒ์„ฑํ•œ๋‹ค. ๊ทธ ๋Œ€์‚ฌ์ฒด์ค‘ ํ•˜๋‚˜์ธ, 17-oxo-DHA๋Š” ํ™œ์„ฑํ™”๋œ ๋Œ€์‹์„ธํฌ์—์„œ COX-2์™€ ํƒˆ์ˆ˜์†Œํšจ์†Œ์— ์˜ํ•ด DHA๋กœ๋ถ€ํ„ฐ ์ƒ์„ฑ๋œ๋‹ค. STAT3๋Š” UVB๋กœ ์œ ๋„๋œ ํ”ผ๋ถ€์—ผ์ฆ ๋ฐ ํ”ผ๋ถ€์•” ๋ฐœ์ƒ์—์„œ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•œ๋‹ค. STAT3์˜ ํ™œ์„ฑํ™”์— ํ•„์ˆ˜์ ์ธ Tyr705์˜ ์ธ์‚ฐํ™”๋Š” 17-oxo-DHA๋กœ ์ฒ˜๋ฆฌ๋œ ๋ฌด๋ชจ ๋งˆ์šฐ์Šค์—์„œ ์œ ์˜ํ•˜๊ฒŒ ๊ฐ์†Œํ•˜์˜€๋‹ค. ๋˜ํ•œ UVB ์กฐ์‚ฌ๋กœ ์ธํ•ด ์œ ๋„๋œ ์„ธํฌ ์‚ฌ๋ฉธ์˜ ๋ฐœ์ƒ์€ 17-oxo-DHA์˜ ๊ตญ์†Œ ๋„ํฌ๋กœ ์ธํ•ด ๊ฒฝ๊ฐ๋˜์—ˆ์œผ๋ฉฐ ์ด๋Š” TUNEL-์–‘์„ฑ ์„ธํฌ์˜ ๋น„์œจ ๊ฐ์†Œ๋กœ ์ž…์ฆํ•˜์˜€๋‹ค. 17-oxo-DHA์˜ ์ฒ˜๋ฆฌ๋Š” ๋˜ํ•œ ์‚ฐํ™”์  ์ŠคํŠธ๋ ˆ์Šค์˜ ์ง€ํ‘œ ๋‹จ๋ฐฑ์งˆ ๋ฐœํ˜„์„ ๊ฐ์†Œ์‹œ์ผฐ๊ณ , Nrf2์˜ ๋ฐœํ˜„๊ณผ ๊ด€๋ จ ํ•ญ์—ผ์ฆ ๋ฐ ํ•ญ์‚ฐํ™” ๋‹จ๋ฐฑ์งˆ ๋ฐœํ˜„์„ ์ฆ๊ฐ€์‹œ์ผœ ์—ผ์ฆ์„ฑ ์‚ฌ์ดํ† ์นด์ธ ์ƒ์„ฑ์„ ์•ฝํ™”์‹œํ‚ค๊ณ , ์—ผ์ฆ์˜ ํ•ด์†Œ๋ฅผ ๊ฐ€์†ํ™”ํ•˜์˜€๋‹ค. ํฌ์‹์ž‘์šฉ์€ ๋Œ€์‹์„ธํฌ์˜ ์‹๊ท ํ™œ๋™์— ์˜ํ•ด ์ˆ˜ํ–‰๋˜๋Š” ์—ผ์ฆ์˜ ํ•ด์†Œ์— ์ค‘์ถ”์ ์ธ ์—ญํ• ์„ ํ•œ๋‹ค. ์ด ์‹คํ—˜์—์„œ 17-oxo-DHA์— ์˜ํ•œ ๊ณจ์ˆ˜ ์œ ๋ž˜ ๋Œ€์‹์„ธํฌ์˜ ํฌ์‹์ž‘์šฉ ๋Šฅ๋ ฅ์˜ ๋ณ€ํ™”๋ฅผ ๊ด€์ฐฐํ•˜์˜€๊ณ , ๊ทธ ๊ฒฐ๊ณผ 17-oxo-DHA์˜ ์ฒ˜๋ฆฌ์— ์˜ํ•ด ๊ณจ์ˆ˜ ์œ ๋ž˜ ๋Œ€์‹์„ธํฌ์˜ ํฌ์‹์ž‘์šฉ์ด ์ฆ๊ฐ€ํ•จ์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋˜ํ•œ ์ด ๊ฒฐ๊ณผ๋Š” ์Šค์บ๋นˆ์ € ์ˆ˜์šฉ์ฒด์ธ CD36 ๋ฐ Nrf2์˜ ๋ฐœํ˜„๋Ÿ‰์˜ ์ฆ๊ฐ€์™€ ๊ด€๋ จ ์žˆ์Œ์„ Nrf2 knockout ๋งˆ์šฐ์Šค๋“ค์„ ํ†ตํ•ด ํ™•์ธํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๊ฒฐ๋ก ์ ์œผ๋กœ, 17-oxo-DHA์˜ ๋„ํฌ๋Š” ์‚ฐํ™”์  ์ŠคํŠธ๋ ˆ์Šค๋ฅผ ์–ต์ œํ•˜๊ณ  ๋Œ€์‹์„ธํฌ์˜ ํฌ์‹์ž‘์šฉ ๋Šฅ๋ ฅ์„ ๊ฐ•ํ™”ํ•˜์—ฌ ์—ผ์ฆ์˜ ํ•ด์†Œ ๋‹จ๊ณ„๋ฅผ ํ™œ์„ฑํ™”์‹œ์ผœ UVB์— ์˜ํ•ด ์œ ๋„๋œ ํ”ผ๋ถ€์—ผ ๋ฐ ํ”ผ๋ถ€์•”์œผ๋กœ๋ถ€ํ„ฐ ๋ณดํ˜ธํšจ๊ณผ๋ฅผ ๋‚˜ํƒ€๋‚ด์—ˆ๊ณ , ์ด๋Ÿฌํ•œ ํšจ๊ณผ๋Š” Nrf2์˜ ํ™œ์„ฑํ™”์™€ ๊ทธ์— ๋”ฐ๋ฅธ ํ•ญ์‚ฐํ™” ๋‹จ๋ฐฑ์งˆ ๋ฐœํ˜„์˜ ์ฆ๊ฐ€๋ฅผ ํ†ตํ•ด ํ™•์ธ๋˜์—ˆ๋‹ค. ๋”ฐ๋ผ์„œ 17-oxo-DHA๋Š” UVB๋กœ ์ธํ•œ ํ”ผ๋ถ€ ์†์ƒ์„ ํ•ด๊ฒฐํ•  ์ˆ˜ ์žˆ๋Š” ์น˜๋ฃŒ์ œ๋กœ์„œ์˜ ๊ฐ€๋Šฅ์„ฑ์ด ์žˆ์Œ์„ ์‹œ์‚ฌํ•œ๋‹ค.Taurine protects tissues from oxidative damage and inflammation through up-regulation of anti-oxidant and anti-inflammatory gene expression and accelerates the biological and structural repair of damaged tissues. During the oxidative burst, hydrogen peroxide (H2O2) is produced, which is converted to highly reactive hypochlorous acid (HOCl) by the myeloperoxidase activity of the activated neutrophils in the presence of chloride ion. HOCl has bactericidal activity, but at the site of acute inflammation, but it can also be detrimental to host. At the inflamed site, taurine reacts with residual HOCl, resulting in the formation of taurine chloramine (TauCl). From previous studies, TauCl is known to inhibit the production of pro-inflammatory mediators of tissue damage, such as chemokines and cytokines in various cells and tissues. In this study, I investigated the protective effect of TauCl against colitis caused by 2,4,6-trinitrobenzene sulfonic acid (TNBS). TauCl administration attenuated oxidative stress as assessed by 4-hydroxy-2-nonenal (4-HNE) production and expression/production of pro-inflammatory factors such as tumor necrosis factor-ฮฑ, interleukin- 6, and cyclooxygenase-2 (COX-2). TauCl also inhibited the activation of two key transcription factors, NFB and STAT3 mediating pro-inflammatory signaling. Specifically, the protective effects of TauCl against oxidative stress and inflammation in the colon of TNBS-treated mice were associated with increased activation of Nrf2 and upregulation of its target genes and proteins. To further elucidate the protective role of TauCl under inflammatory conditions, an experimentally induced murine dermatitis model was employed. Excessive exposure to solar radiation, especially ultraviolet rays, causes extensive photodamage, a major cause of dermatitis and skin cancer. Upon irradiation of ultraviolet B (UVB) at an intensity of 180 mJ/cm2 induced oxidative damage and cell death in the epidermis of mice. These symptoms were alleviated through the topical application of TauCl. In addition, the UVB-induced expression of pro-inflammatory cytokines was lower in the skin of TauCl treated mice than that of the vehicle-treated control group. The anti-inflammatory effects of TauCl are related to the inhibition of STAT3 signaling with concomitant activation of Nrf2 and induction of antioxidant enzymes such as heme oxygenase-1 and NAD(P)H:quinone oxidoreductase 1. Taken together, these results suggest that TauCl exerts protective effects against colitis and dermatitis through the upregulation of Nrf2-dependent cytoprotective gene expression while downregulation of proinflammatory signaling mediated by NFฮบB and STAT3. Docosahexaenoic acid (DHA) is one of the prototype omega-3 (ฯ‰-3) polyunsaturated fatty acids and has been reported to inhibit inflammatory and carcinogenic processes. 17-Oxo-DHA is an electrophilic fatty acid metabolite, produced from DHA via a series of steps involving COX-2 and dehydrogenase in activated macrophages. 17-Oxo-DHA was found to play an important role in UVB-induced dermatitis and photocarcinogenesis. In the present study, it was confirmed that UVB-induced phosphorylation of Tyr705, which is essential for the activation of STAT3, was inhibited by topically applied 17-oxo-DHA in mouse skin in vivo. Topical application of 17-oxo-DHA reduced the expression of oxidative stress markers in UVB-irradiated mouse skin. These protective effects were associated with the inhibition of inflammatory cytokines and acceleration of the resolution of inflammation through activation of Nrf2 and concurrent upregulation of anti-inflammatory and antioxidant proteins. Macrophages play an essential role in the resolution of inflammation by exerting the phagocytic activity. Treatment with 17-oxo-DHA enhanced the engulfment of dead epidermal cells by macrophages. These effects were attributable to increased expression of the scavenger receptor, CD36 induced by Nrf2. In conclusion, 17-oxo-DHA inhibits oxidative stress and inflammation as well as enhances the efferocytosis activity of macrophages to accelerate the resolution phase. These effects were associated with elevated expression of antioxidant and anti-inflammatory/proresolving proteins via the activation of the Nrf2 signal pathway. Thus, 17-oxo-DHA is an endogenous molecule with the potential as a therapeutic agent to alleviate inflammatory symptoms.Chapter I. Taurine Chlroramine and 17-Oxo-Docosahexaenoic Acid as Novel Endogenous Proresolving and Anti-inflammatory Substances with Chemopreventive Potential 1 1. Introduction 2 2. NF-ฮบB and STAT3 as two representative proinflammatory signaling molecules 4 3. Taurine chloramine 6 4. 17-Oxo-docosahexaenoic acid (17-Oxo-DHA) 8 5. Regulation of the Nrf2 signaling pathway by taurine chloramine and 17-oxo-DHA 9 6. References 14 Statement of Purpose 21 Chapter โ…ก. Protective Effects of Taurine Chloramine on Experimentally Induced Colitis: NFฮบB, STAT3, and Nrf2 as Potential Targets 22 1. Abstract 23 2. Introduction 25 3. Materials and Methods 28 4. Results 36 5. Discussion 52 6. References 56 Chapter โ…ข. Topically Applied Taurine Chloramine Protects Against UVB-induced Oxidative Stress and Inflammation in Mouse Skin 60 1. Abstract 61 2. Introduction 63 3. Materials and Methods 65 4. Results 73 5. Discussion 86 6. References 90 Chapter โ…ฃ. Protective Effects of an Electrophilic Metabolite of Docosahexaenoic Acid on UVB-induced Oxidative Cell Death, Dermatitis, and Carcinogenesis 99 1. Abstract 100 2. Introduction 102 3. Materials and Methods 105 4. Results 117 5. Discussion 152 6. References 157 Conclusion 166 Abstract in Korean 167๋ฐ•

    The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study

    Get PDF
    BACKGROUND: Despite recent advances in diagnosis and treatment, cervical cancer continues to be a significant health problem worldwide. Whereas robot-assisted surgery has advantages over the abdominal approach, and minimally invasive techniques are being used increasingly, these may be associated with a higher recurrence rate and lower overall survival than the abdominal approach. The objective of this study was to compare the surgical and survival outcomes between abdominal radical hysterectomy (ARH) and robotic radical hysterectomy (RRH). METHODS: A retrospective cohort of patients undergoing radical hysterectomy for cervical cancer from 2006 to 2018 was identified. Patients with stage IA to IB cervical cancer were included and grouped: ARH vs. RRH. The RRH group was further divided into two groups based on the year of enrollment: RRH1 (2006-2012) and RRH2 (2013-2018). Tumor characteristics, recurrence rate, progression-free survival (PFS), and overall survival (OS) were compared between the groups. P-values <โ€‰0.05 (two-sided) were considered statistically significant. RESULTS: A total of 310 patients were identified: 142 and 168 underwent ARH and RRH, respectively. RRH1 and RRH2 had 77 and 91 patients, respectively. Interestingly, RRH2 was more likely to have a larger tumor size (1.7โ€‰ยฑโ€‰1.4 vs. 2.0โ€‰ยฑโ€‰1.1 vs. 2.4โ€‰ยฑโ€‰1.7โ€‰cm, Pโ€‰=โ€‰0.014) and higher stage (Pโ€‰<โ€‰0.001) than RRH1. However, RRH2 showed significantly favorable PFS in contrast to RRH1. There was no difference between ARH and RRH2 in PFS (Pโ€‰=โ€‰0.629), whereas overall, the RRH group showed significantly shorter PFS than the ARH group. In the multivariate analysis, the institutional learning curve represented by the operation year was one of the significant predictors for PFS (hazard ratio [HR] 0.065, Pโ€‰=โ€‰0.0162), along with tumor size (HR 5.651, Pโ€‰=โ€‰0.0241). CONCLUSIONS: The institutional learning curve, represented by the operation year, is one of the most significant factors associated with outcomes of RRH for early-stage cervical cancer.ope

    Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer

    Get PDF
    BACKGROUND: Poly (ADP-ribose) polymerase inhibitors targeting BRCA1/2 mutations are available for treating patients with high-grade serous ovarian cancer. These treatments may be more appropriately directed to patients who might respond if the tumor tissue is additionally tested by next-generation sequencing with a multi-gene panel and Sanger sequencing of a blood sample. In this study, we compared the results obtained using the next-generation sequencing multi-gene panel to a known germline BRCA1/2 mutational state determined by conventional Sanger sequencing to evaluate the landscape of somatic mutations in high-grade serous ovarian cancer tumors. METHODS: Cancer tissue from 98 patients with high-grade serous ovarian cancer who underwent Sanger sequencing for germline BRCA1/2 analysis were consecutively analyzed for somatic mutations using a next-generation sequencing 170-gene panel. RESULTS: Twenty-four patients (24.5%) showed overall BRCA1/2 mutations. Seven patients (7.1%) contained only somatic BRCA1/2 mutations with wild-type germline BRCA1/2, indicating acquired mutation of BRCA1/2. Three patients (3.1%) showed reversion of germline BRCA1 mutations. Among the 14 patients (14.3%) with both germline and somatic mutations in BRCA1/2, two patients showed different variations of BRCA1/2 mutations. The next-generation sequencing panel test for somatic mutation detected other pathogenic variations including RAD51D and ARID1A, which are possible targets of poly (ADP-ribose) polymerase inhibitors. Compared to conventional Sanger sequencing alone, next-generation sequencing-based tissue analysis increased the number of candidates for poly (ADP-ribose) polymerase inhibitor treatment from 17.3% (17/98) to 26.5% (26/98). CONCLUSIONS: Somatic mutation analysis by next-generation sequencing, in addition to germline BRCA1/2 mutation analysis, should become the standard of care for managing women with high-grade serous ovarian cancer to widen the indication of poly (ADP-ribose) polymerase inhibitors.ope

    Establishment of a novel malignant Brenner tumer cell Line

    Get PDF
    Objective: Ovarian cancer is the most lethal disease among gynecologic malignancies. Although many efforts have been made to explore the mechanisms involved in its development, the genetic events in the pathogenesis of ovarian cancer are still unclear. We characterized a cell line (designated OHK) established from a malignant Brenner tumor cell. Methods: The cells were obtained during the operation of a 43-year-old Korean woman with ovarian cancer. The OHK cells continuously propagated in vitro over a period of about 36 months and, to date, have undergone over 200 passages, without being infected by either Mycoplasma or any bacteria. We measured the doubling time of OHK cells. To investigate the tumorigenecity of OHK, cells were inoculated subcutaneously into the back of nude mice. Several tumor markers were analyzed using culture media and lysates of cytosol. Morphology and ultrastructure were analyzed by phase-contrast microscopy and electron microscopy. OHK was also analyzed for gene mutation, the typing of human leukocyte antigen and Flow cytometric cell cycle analysis and DNA index. Results: They proliferated in a monolayered sheet showing a pavement-like arrangement without suppression by intercellular contacts. They also formed epithelial cell lining in shapes of polymorphism and polygons. Doubling time was 38.4 hour which was relatively slow compared to other cancer cells. Microscopic view revealed intranuclear infoldings which are typical in malignant Brenner tumors. The OHK cells secreted significantly high level of CA 125 into the culture medium. A 215th codon at exon 4 of p53 was mutated to C/C in OHK. BRCA 1 was a wild type and polymorphisms were detected in exons 2, 10, 11, 14 and 17 of BRCA 2. The cells showed aneuploidy with DNA index of 1.589 measured by flow cytometry. When transplanted into nude mice, OHK cells successfully induced tumor which was histopathologically resembled malignant Brenner tumor. Conclusion: These results strongly suggest that OHK is a typical cell line of malignant Brenner tumor. This may provide a useful cellular resource for studying the pathogenesis of malignant Brenner tumor.ope

    Enhancement of Ablative Characteristics of Phenolic Composites by Adding CNT

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ๊ธฐ๊ณ„ํ•ญ๊ณต๊ณตํ•™๋ถ€(๋ฉ€ํ‹ฐ์Šค์ผ€์ผ ๊ธฐ๊ณ„์„ค๊ณ„์ „๊ณต), 2014. 2. ์ด์šฐ์ผ.Composite materials are widely replacing previous traditional materials such as metals, woods and polymeric materials. The phenolic matrix can be modified by adding materials in order to improve the mechanical properties especially thermal resistance and abrasion. In this study, Carbon Nanotube(CNT) is used as a reinforcement particle to the phenolic resin for the purpose of improving ablative characteristics. Composite containing CNT shows advanced ablation characteristics in comparison with neat phenolic resin. CNT affects degree of crystallization of specimen with functioning as a crystalline nucleus in abrasion process. X-ray Diffraction(XRD) and SEM were carried out to confirm changing degree of crystallization of CNT-reinforced phenolic composites.ABSTRACT 1 TABLE OF CONTENTS 3 LIST OF TABLES AND FIGURES 4 INTRODUCTION 7 1.1 INTRODUCTION 7 1.2 BACKGROUND THEORY 10 1.2.1 Ablation 10 1.2.2 Crystallization 11 1.3 PURPOSE OF STUDY 13 2 MATERIALS AND EXPERIMENTAL 14 2.1 MATERIALS 14 3.1 Phenolic resin 14 3.2 Carbon Nanotube 16 2.2 PREPARATION OF THE SPECIMENS 17 2.2.1 Dispersion of CNT 17 2.2.2 Curing Process 18 2.3 MEASUREMENTS 19 2.3.1 Ablation Experimental 19 2.3.2 X-ray Diffraction(XRD) 20 2.3.3 Raman Spectroscopy 23 2.3.4 Scanning Electron Microscope 24 3. RESULT AND DISCUSSION 25 3.1 ABLATION RATIO OF COMPOSITES BY ADDING CNT 25 3.2 XRD 26 3.3 RAMAN SPECTROSCOPY 27 3.4 SEM 27 4. CONCLUSIONS AND FUTURE WORK 28 REFERENCES 30 ์ดˆ ๋ก 54Maste

    Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study

    Get PDF
    Objective: To evaluate the effectiveness and safety of the combination of pegylated liposomal doxorubicin with carboplatin (CD) compared with those of carboplatin and paclitaxel (CP) for platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer in a real-world setting in Korea. Methods: We enrolled relevant patients from 9 institutions. All patients received CD or CP as the second- or third-line chemotherapy in routine clinical practice during 2013-2018. The primary endpoints were progression-free survival (PFS) and toxicity. The secondary endpoint included the objective response rate (ORR). Results: Overall, 432 patients (224 and 208 in the CD and CP groups, respectively) were included. With a median follow-up of 18.9 months, the median PFS was not different between the groups (12.7 vs. 13.6 months; hazard ratio, 1.161; 95% confidence interval, 0.923-1.460; p=0.202). The ORR was 74.6% and 80.1% in the CD and CP group, respectively (p=0.556). Age and surgery at relapse were independent prognostic factors. More patients in the CD group significantly experienced a grade 3 to 4 hematologic toxicity and hand-foot syndrome (13.8% vs. 6.3%), whereas grade 2 or more alopecia (6.2% vs. 36.1%), peripheral neuropathy (4.4% vs. 11.4%), and allergic/hypersensitivity reaction (0.4% vs. 8.5%) developed more often in the CP group. Conclusions: The safety and effectiveness of chemotherapy with CD in a real-world setting were consistent with the results from a randomized controlled study. The different toxicity profiles between the 2 chemotherapy (CD and CP) regimens should be considered in the clinical practice. Trial registration: ClinicalTrials.gov Identifier: NCT03562533.ope

    Corporate Governance and Firm Environmental Disclosure: In the context of a Family Firm Dominated Economy

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ๊ฒฝ์˜ํ•™๊ณผ ๊ฒฝ์˜ํ•™์ „๊ณต, 2016. 8. ์ด๋™๊ธฐ.Grounded on institutional theory, much environmental management research has regarded that corporations would make the same strategic choices when facing common sets of institutional pressures. In this study, we consider corporation's responsiveness to environmental policy and regulation is different and they exhibit heterogeneous strategies depending on its distinct governance mechanism. By focusing on firm environmental disclosure which is a way of corporations voluntary action against climate change issue, we examine how corporate ownership structure and board composition affect corporations heterogeneous environmental strategies, especially in the family firm dominated economy. As a result of the logistic regression analysis with the sample of 241 Korean firms, we find that under the concentrated ownership structure, the foreign and institutional investors and the outside directors play an important role in encouraging firms to actively engage in firm environmental disclosure, while controlling shareholders group has a negative impact on the disclosure. In the current situation where the firms participation is significantly underscored in solving global environmental problems, this study gives meaningful implications for environmental policy makers to design the most effective corporate environmental programs along with theoretical and managerial implications.1. INTRODUCTION 1 2. THEORY & HYPOTHESES 3 2.1. Institutional pressures and corporate environmental strategy 3 2.2. Corporate Governance and Firm Environmental Disclosure 5 2.3. Ownership structure in the family firm dominated economy 7 2.4. Corporate ownership structure 8 2.4.1. CS ownership and managerial ownership 8 2.4.2. Institutional ownership and foreign ownership 11 2.5. Board composition 13 2.5.1. Board Independence: the proportion of outside directors in the board 13 2.5.2. Independence of board committee: Independent audit committee 15 3. METHODS 18 3.1. Sample and Data collection 18 3.2. Measures 20 3.2.1. Independent variable 20 3.2.2. Dependent variable 20 3.2.3. Control variables 21 3.3. Estimation method 23 4. RESULTS 24 5. DISCUSSION 28 6. CONCLUSION 30 REFERENCES 34 TABLES 41 ๊ตญ๋ฌธ ์ดˆ๋ก 44Maste
    • โ€ฆ
    corecore